Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-27 @ 7:10 PM
Study NCT ID:
NCT00722293
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2008-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07-08
Start Date Type:
ACTUAL
Primary Completion Date:
2012-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02-25
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-23
First Submit QC Date:
None
Study First Post Date:
2008-07-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-08
Last Update Post Date:
2017-11-13
Last Update Post Date Type:
ACTUAL